These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18501072)

  • 1. Evaluation of quality of life in patients with metastatic colorectal cancer treated with capecitabine.
    Segalla JG; Van Eyll B; Federico MH; Skare NG; Franke FA; Perdicaris MR; Filho Ude P; Gampel O; Cabral S; Ribeiro Rde A
    Clin Colorectal Cancer; 2008 Mar; 7(2):126-33. PubMed ID: 18501072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life and cost comparison of adjuvant capecitabine versus 5-fluorouracil/leucovorin in stage III colorectal cancer patients.
    Chen HH; Chen WT; Lee HC; Lin JK; Fang CY; Chou YH; Lin PC; Lin BW; Huang CC; Yeh CH; Hsu HH; Chen HC; Ting WC; Yang MC; Tan EC
    Qual Life Res; 2015 Feb; 24(2):473-84. PubMed ID: 25099199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing the effectiveness of capecitabine versus 5-fluorouracil/leucovorin therapy for elderly Taiwanese stage III colorectal cancer patients based on quality-of-life measures (QLQ-C30 and QLQ-CR38) and a new cost assessment tool.
    Lin JK; Tan EC; Yang MC
    Health Qual Life Outcomes; 2015 May; 13():61. PubMed ID: 25986478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life in non-early rectal cancer treated by neoadjuvant radio-chemotherapy and endoluminal loco-regional resection (ELRR) by transanal endoscopic microsurgery (TEM) versus laparoscopic total mesorectal excision.
    D'Ambrosio G; Paganini AM; Balla A; Quaresima S; Ursi P; Bruzzone P; Picchetto A; Mattei FI; Lezoche E
    Surg Endosc; 2016 Feb; 30(2):504-511. PubMed ID: 26045097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality-of-life impairment after endoluminal locoregional resection and laparoscopic total mesorectal excision.
    Lezoche E; Paganini AM; Fabiani B; Balla A; Vestri A; Pescatori L; Scoglio D; D'Ambrosio G; Lezoche G
    Surg Endosc; 2014 Jan; 28(1):227-34. PubMed ID: 24002918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical function and quality of life in frail and/or elderly patients with metastatic colorectal cancer treated with capecitabine and bevacizumab: an exploratory analysis.
    Ward P; Hecht JR; Wang HJ; Dichmann R; Liem AK; Chan D; Patel R; Hu EH; Tchekmedyian NS; Wainberg ZA; Naeim A
    J Geriatr Oncol; 2014 Oct; 5(4):368-75. PubMed ID: 25002322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life in non-metastasic colorectal cancer patients in FOLFOX or XELOX therapy.
    Sánchez-Gundín J; Fernández-Carballido AM; Torres-Suárez AI; Barreda-Hernández D
    Farm Hosp; 2019 Mar; 43(2):56-60. PubMed ID: 30848178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised study of tegafur-uracil plus leucovorin versus capecitabine as first-line therapy in elderly patients with advanced colorectal cancer--TLC study.
    Kroep JR; van Werkhoven E; Polee M; van Groeningen CJ; Beeker A; Erdkamp F; Weijl N; van Bochove A; Erjavec Z; Kapiteijn E; Stiggelbout AM; Nortier HW; Gelderblom H
    J Geriatr Oncol; 2015 Jul; 6(4):307-15. PubMed ID: 26073532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Danish version of the disease specific instrument EORTC QLQ-CR38 to assess health-related quality of life in patients with colorectal cancer.
    Thaysen HV; Jess P; Laurberg S; Groenvold M
    Health Qual Life Outcomes; 2012 Dec; 10():150. PubMed ID: 23241096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life.
    Sprangers MA; te Velde A; Aaronson NK
    Eur J Cancer; 1999 Feb; 35(2):238-47. PubMed ID: 10448266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the FACT-C, EORTC QLQ-CR38, and QLQ-CR29 quality of life questionnaires for patients with colorectal cancer: a literature review.
    Ganesh V; Agarwal A; Popovic M; Cella D; McDonald R; Vuong S; Lam H; Rowbottom L; Chan S; Barakat T; DeAngelis C; Borean M; Chow E; Bottomley A
    Support Care Cancer; 2016 Aug; 24(8):3661-8. PubMed ID: 27193118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in patients with advanced colorectal cancer: results from a phase II study of S-1 combined with irinotecan (CPT-11).
    Tsunoda A; Yasuda N; Nakao K; Narita K; Watanabe M; Matsui N; Tsunoda Y; Kusano M
    Int J Clin Oncol; 2010 Jun; 15(3):280-6. PubMed ID: 20232103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on adherence to capecitabine among patients with colorectal cancer and metastatic breast cancer.
    Figueiredo Junior AG; Forones NM
    Arq Gastroenterol; 2014; 51(3):186-91. PubMed ID: 25296077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life in a randomized trial comparing two neoadjuvant regimens for locally advanced rectal cancer-INCAGI004.
    Araujo RO; Vieira FM; Victorino AP; Torres C; Martins I; Guaraldi S; Valadão M; Linhares E; Ferreira CG; Thuler LC
    Support Care Cancer; 2022 Aug; 30(8):6557-6572. PubMed ID: 35486228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of personality in the course of health-related quality of life and disease-specific health status among colorectal cancer survivors: A prospective population-based study from the PROFILES registry.
    Husson O; Vissers PA; Denollet J; Mols F
    Acta Oncol; 2015 May; 54(5):669-77. PubMed ID: 25752968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II clinical trial of preoperative combined chemoradiation for T3 and T4 resectable rectal cancer: preliminary results.
    Tjandra JJ; Reading DM; McLachlan SA; Gunn IF; Green MD; McLaughlin SJ; Millar JL; Pedersen JS
    Dis Colon Rectum; 2001 Aug; 44(8):1113-22. PubMed ID: 11535850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative chemoradiation for locally advanced rectal cancer with capecitabine 2,000 mg/m2/day.
    Veerasarn V; Boonnuch W; Chinswangwatanakul V; Lohsiriwat D; Mahamadsolaeh P
    J Med Assoc Thai; 2008 Oct; 91(10):1583-8. PubMed ID: 18972903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost analysis of capecitabine vs 5-fluorouracil-based treatment for metastatic colorectal cancer patients.
    De Portu S; Mantovani LG; Ravaioli A; Tamburini E; Bollina R; Cozzi C; Grimaldi AM; Testa TE; Bianchessi C; Carteni G
    J Chemother; 2010 Apr; 22(2):125-8. PubMed ID: 20435573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health utility scores of colorectal cancer based on societal preference in Japan.
    Shiroiwa T; Fukuda T; Tsutani K
    Qual Life Res; 2009 Oct; 18(8):1095-103. PubMed ID: 19626462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study.
    Van Cutsem E; Twelves C; Cassidy J; Allman D; Bajetta E; Boyer M; Bugat R; Findlay M; Frings S; Jahn M; McKendrick J; Osterwalder B; Perez-Manga G; Rosso R; Rougier P; Schmiegel WH; Seitz JF; Thompson P; Vieitez JM; Weitzel C; Harper P;
    J Clin Oncol; 2001 Nov; 19(21):4097-106. PubMed ID: 11689577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.